Healthcare logistics scale Movianto operates a expansive European pharmaceutical distribution network with 23 distribution centres and over 600,000 pallet spaces, offering temperature-controlled warehousing and last-mile delivery. Sales opportunities lie in scaling to additional EU markets, expanded cold-chain capacity, and integrated cross-border distribution for pharma and medtech clients.

Strategic NHS UK tie A five-year contract with NHS England positions Movianto as a trusted end-to-end vaccine storage, inventory management, and GDP-compliant distribution partner to 11,000 healthcare locations. Potential upsell includes expanded vaccine rollouts, additional storage capacities, and broader regional distribution services for public health initiatives.

GMP and temp control Plans to introduce GMP operations in Germany’s refrigerated area indicate capabilities for specialized handling and manufacturing support under strict temperature control. This creates cross-sell opportunities for pharma manufacturers seeking compliant co-packaging, manufacturing support, and value-added services within cold chains.

Recent capacity expansion New 30,000 square metre logistics hub in Germany with 10,000 pallet positions and planned operational readiness by November 2026 signals capacity growth to meet rising demand. Target customers include mid- to large-scale pharma, biotech, and medical device manufacturers needing scalable, compliant distribution with robust service levels.

Acquisition momentum Movianto’s acquisition by major players (Walden Group and Nippon Yusen Kaisha) and integration into Yusen Logistics Healthcare enhances credibility and cross-sell opportunities across a broader global logistics ecosystem. Leverage alliance to present multinational end-to-end supply chain solutions, including digital platforms (SAP, Power BI, Salesforce) for customers pursuing global alignment and data-driven logistics optimization.